Evidence map›Paper›PMID 40589906›Full record

ArticleERJ open research2025

Upper-lobe CT imaging features improve prediction of lung function decline in COPD.

Kalysta Makimoto, Sukhraj Virdee, Meghan Koo, James C Hogg, Jean Bourbeau, Wan C Tan, Miranda Kirby

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kalysta MakimotoToronto Metropolitan University, Ontario, Canada.ORCID https://orcid.org/0000-0002-1927-7056
Sukhraj VirdeeToronto Metropolitan University, Ontario, Canada.
Meghan KooToronto Metropolitan University, Ontario, Canada.ORCID https://orcid.org/0000-0002-4853-1447
James C HoggCenter for Heart, Lung Innovation, University of British Columbia, Vancouver, Canada.
Jean BourbeauMontreal Chest Institute of the Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-7649-038X
Wan C TanCenter for Heart, Lung Innovation, University of British Columbia, Vancouver, Canada.
Miranda KirbyToronto Metropolitan University, Ontario, Canada.ORCID https://orcid.org/0000-0003-2951-784X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is unknown whether prediction models for lung function decline using computed tomography (CT) imaging-derived features from the upper lobes improve performance compared with globally derived features in individuals at risk of and with COPD. Methods: Individuals at risk (current or former smokers) and those with COPD from the Canadian Cohort Obstructive Lung Disease (CanCOLD) retrospective study, were investigated. A total of 103 CT features were extracted globally and regionally, and were used with 12 clinical features (demographics, questionnaires and spirometry) to predict rapid lung function decline for individuals at risk and those with COPD. Machine-learning models were evaluated in a hold-out test set using the area under the receiver operating characteristic curve (AUC) with DeLong's test for comparison. Results: A total of 780 participants were included (n=276 at risk; n=298 Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 COPD; n=206 GOLD 2+ COPD). For predicting rapid lung function decline in those at risk, the upper-lobe CT model obtained a significantly higher AUC (AUC=0.80) than the lower-lobe CT model (AUC=0.63) and global model (AUC=0.66; p<0.05). For predicting rapid lung function decline in COPD, there was no significant differences between the upper-lobe (AUC=0.63), lower-lobe (AUC=0.59) or global CT features model (AUC=059; p>0.05). Conclusion: CT features extracted from the upper lobes obtained significantly improved prediction performance compared with globally extracted features for rapid lung function decline in early/mild COPD.

Identifiers

PMID40589906
PMCPMC12208604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.